Successful lamivudine therapy for chronic hepatitis B in the family | Zendy

Darko Nožić | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Successful lamivudine therapy for chronic hepatitis B in the family

Author(s) -

Darko Nožić

Publication year - 2006

Publication title -

vojnosanitetski pregled

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.123

H-Index - 19

eISSN - 2406-0720

pISSN - 0042-8450

DOI - 10.2298/vsp0605504n

Subject(s) - lamivudine , adefovir , medicine , hepatocellular carcinoma , cirrhosis , chronic hepatitis , entecavir , hepatitis b , hepatitis b virus , virology , virus , immunology , gastroenterology

Hepatitis B virus infection is a global public health problem since it is a leading cause of liver cirrhosis and hepatocellular carcinoma. An optimal treatment is needed to reduce mortality. Current therapies for chronic hepatitis B include standard and pegilated interferon-alfa and nucleoside and nucleotide analogies, primarily lamivudine and adefovir. Each of the therapies, however has various limitations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research